Pharmacologic Modulation of Luminal Carbohydrate Digestion Improves Insulinogenic, Glycemic and Lipid Parameters in Obese, Hyperinsulinemic T2DM Rats
Japanese Journal of Medical Research · 2025
DOI: 10.33425/2993-6799.1021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Medical Research, 2025. Verfasst von Orien L Tulp und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Atherogenic plasma lipid and glycemic profiles are a common observation in obesity and adult-onset diabetes (T2DM) and may become improved following therapeutic intervention. The effects of the luminal α-glucosidase inhibitor miglitol (MIG) on carbohydrate (CHO) digestion on plasma lipid profiles were determined in groups of adult male obese SHR/Ntul//-cp rats, a genetic model that develops early-onset obesity+T2DM independently of diet. Rats were fed a USDA-formulated, complete diet containing 54% sucrose as the CHO component (Control) or the same diet containing MIG at 150 mg/kg diet admixture ad libitum for < 8 weeks. MIG resulted in a ~15% decrease in energy intake (p = < 0.05), net weight gain (p = < 0.05), and 14% decrease in adiposity (p= < 0.05), in addition to significant (p = < 0.05) decreases in fasting glucose, insulin, glycated hemoglobin, a 20% reduction in glucose area under the curve (AUC; p = < 0.05) a 15% reduction in triglycerides, p = < 0.05) and a 20% reduction in total cholesterol, α- (LDL) and β-lipoprotein (HDL) fractions (p = < 0.05, all comparisons) after the MIG regimen. Liver glucokinase, malic enzyme and glucose-6-phosphate dehydrogenase were also decreased following the MIG regimen (p = < 0.05). In conclusion, these results indicate that therapeutic αglucosidase inhibition via MIG resulted in improvements in multiple insulin-linked atherogenic parameters and may be a useful adjunct in the long-term clinical management of plasma lipid and glycemic profiles in the glucose intolerant states of obesity and T2DM.
Zitieren
APA
Tulp, O. L., & Rizvi, S. A. (2025). Pharmacologic Modulation of Luminal Carbohydrate Digestion Improves Insulinogenic, Glycemic and Lipid Parameters in Obese, Hyperinsulinemic T2DM Rats. Japanese Journal of Medical Research. https://doi.org/10.33425/2993-6799.1021
Vancouver
Tulp OL, Rizvi SA. Pharmacologic Modulation of Luminal Carbohydrate Digestion Improves Insulinogenic, Glycemic and Lipid Parameters in Obese, Hyperinsulinemic T2DM Rats. Japanese Journal of Medical Research. 2025. doi:10.33425/2993-6799.1021
BibTeX
@article{Tulp2025,
author = {Tulp, Orien L and Rizvi, Syed AA},
title = {Pharmacologic Modulation of Luminal Carbohydrate Digestion Improves Insulinogenic, Glycemic and Lipid Parameters in Obese, Hyperinsulinemic T2DM Rats},
journal = {Japanese Journal of Medical Research},
year = {2025},
doi = {10.33425/2993-6799.1021}
}
EUVIMED